J. C. Zong, D. M. Ciufo, D. J. Alcendor, X. Wan, J. Nicholas, P. J. Browning, et al., “High-Level Variability in the ORF-K1 Membrane Protein Gene at the Left End of the Kaposi’s Sarcoma-Associated Herpesvirus Genome Defines Four Major Virus Subtypes and Multiple Variants or Clades in Different Human Populations,” Journal of Virology, Vol. 73, No. 5, 1999, pp. 4156-4170.

has been cited by the following article:

• TITLE: The Role of Human Herpesvirus 8 Molecular Characterization in the Management of HIV Infected Patients Diagnosed with Malignancies Associated with Its Infection

  AUTHORS: Martínez Pedro Ariel, Kourí Vivian, Blanco Orestes, Capó Virginia, Abad Yoandra, Alemán Yoan, Verdasquera Denis, Jiménez Narciso, Caballero Iraida, Fleites Gilberto, Ugarte Yaumara, Calderón Odalys, Álvarez Alina, Ulrich Hengge

  KEYWORDS: Human Herpesvirus 8 or Kaposi’s Sarcoma-Associated Herpesvirus; Real Time PCR; Subtypes; Lymphoproliferative Disorders; Cuban; HIV/AIDS

  JOURNAL NAME: World Journal of AIDS, Vol.3 No.3, September 5, 2013

  ABSTRACT: Despite the progress has been reached with Human herpesvirus 8 (HHV-8) research, there are gaps in the knowledge of viral induced oncogenesis. The aim of the present study was to identify possible associations between HHV-8 subtypes, HHV-8 loads and clinical manifestations of HIV infected patients diagnosed with different malignancies associated with HHV-8 infection. Forty six HIV-1 infected individuals diagnosed with different HHV-8 associated diseases were studied [37 epidemic Kaposi’s sarcoma (KS), 3 pleural effusion lymphoma (PEL); 5 peripheral lymphadenopathies (PL); 1 Hodgkin’s lymphoma (HL); 1 non Hodgkin’s lymphoma (NHL)]. HHV-8 loads were determined by quantitative real time PCR (qRT-PCR) whilst HHV-8 subtypes were determined by open-reading frame (ORF)-K1 gen genotyping. HHV-8 subtypes B, A, C, A5 and E were exhibited by 31.8%, 23.4%, 19.1%, 17% and 8.5% of the studied patients, respectively. The median HHV-8 viral load did not differ between subtypes (p > 0.05) but HHV-8 viral loads were significantly higher in PEL than in epidemic KS lesion or lymph nodes (p = 0.04). Subtype B was detected in 60% of patients with B cell lymphoma (NHL, PEL and HL) whereas subtype E was only detected in patients with epidemic KS diagnosis. Our data suggest that HHV-8 DNA quantification instead of subtype identification could be used as a surrogate marker for monitoring its infection, not only in epidemic KS patients but also in HIV infected individuals with lymphoproliferative disorders.